Moreover, inflammatory mediators such as prostaglandin E2 and inflammatory cytokines (TNF-α, Il-6) have been shown to exacerbate the related pain and decrease in mobility or physical activity in patients with rheumatoid arthritis and other joint diseases [77–79]. This evidence concerns the gene TNF and rheumatoid arthritis.